Literature DB >> 7887754

How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia.

D W Bates1, K E Pruess, T H Lee.   

Abstract

BACKGROUND: To evaluate the short-term and long-term outcomes of patients with suspected bacteremia, we performed a prospective cohort study.
METHODS: Clinical data were collected within 24 hours of initial culture from a random sample of 1516 episodes in which blood cultures were performed in an urban tertiary care hospital. One hundred forty-two patients with bacteremia were compared with two comparison groups: (1) 142 randomly selected patients with negative cultures, matched in age within 5 years, gender, severity of underlying disease, and presence of major comorbidity, and (2) all 155 patients with contaminant cultures. The main outcome measures were death, death secondary to bacteremia, and major complications.
RESULTS: In the 439 patients, there were 142 deaths (32%), 114 at 1 year (26%) and 46 within 30 days (11%). Mortality at 30 days was most highly correlated with predicted fatality of underlying disease: 48% for the 65 patients with a rapidly fatal disease, 9% for the 156 patients with an eventually fatal disease, and 0.5% for the 217 patients with no fatal disease. In a Cox survival analysis, the risk ratio associated with bacteremia was 1.6 (95% confidence interval, 1.0 to 2.4) vs the comparison groups. When we performed time-dependent Cox analyses in which the hazard ratio was allowed to change at 30 days, we found that the risk ratios associated with bacteremia were 2.3 (95% confidence interval, 1.2 to 4.4) for the first 30 days, and 1.3 (95% confidence interval, 0.76 to 2.1) after 30 days.
CONCLUSIONS: We conclude that this population has a high mortality, which is strongly correlated with severity of underlying disease. Short-term mortality was higher in patients with bacteremia even after controlling for severity of illness, but the increase in risk was present only during the first month and most deaths occurred in patients with a rapidly fatal disease.

Entities:  

Mesh:

Year:  1995        PMID: 7887754

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  35 in total

Review 1.  The difficulties of clinical trials evaluating therapeutic agents in patients with severe sepsis.

Authors:  T C Hall; D K Bilku; D Al-Leswas; C Horst; A R Dennison
Journal:  Ir J Med Sci       Date:  2011-11-08       Impact factor: 1.568

2.  David Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford Roberts.

Authors:  David Westfall Bates
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 3.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.

Authors:  David H Wyllie; Derrick W Crook; Tim E A Peto
Journal:  BMJ       Date:  2006-06-23

5.  Improving early management of bloodstream infection: a quality improvement project.

Authors:  Jane Minton; James Clayton; Jonathan Sandoe; Hugh Mc Gann; Mark Wilcox
Journal:  BMJ       Date:  2008-02-23

6.  Impact of bloodstream infection on outcomes among infected surgical inpatients.

Authors:  D P Raymond; S J Pelletier; T D Crabtree; T G Gleason; T L Pruett; R G Sawyer
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

7.  Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.

Authors:  Ching-Chi Lee; Jiun-Ling Wang; Chung-Hsun Lee; Chih-Chia Hsieh; Yuan-Pin Hung; Ming-Yuan Hong; Hung-Jen Tang; Wen-Chien Ko
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

8.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia.

Authors:  Michael Y Lin; Robert A Weinstein; Bala Hota
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.